These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 21423852)
1. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852 [TBL] [Abstract][Full Text] [Related]
2. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Gatski M; Martin DH; Levison J; Mena L; Clark RA; Murphy M; Henderson H; Schmidt N; Kissinger P Sex Transm Infect; 2011 Apr; 87(3):205-8. PubMed ID: 21278401 [TBL] [Abstract][Full Text] [Related]
3. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393 [TBL] [Abstract][Full Text] [Related]
4. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023 [TBL] [Abstract][Full Text] [Related]
5. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women. Adamski A; Clark RA; Mena L; Henderson H; Levison J; Schmidt N; Gebrekristos HT; Martin DH; Kissinger P Clin Infect Dis; 2014 Sep; 59(6):883-7. PubMed ID: 24917661 [TBL] [Abstract][Full Text] [Related]
6. A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women. Muzny CA; Mena LA; Lillis RA; Schmidt N; Martin DH; Kissinger P Sex Transm Dis; 2022 Mar; 49(3):231-236. PubMed ID: 34694277 [TBL] [Abstract][Full Text] [Related]
7. The Association Between Human Immunodeficiency Virus and Bacterial Vaginosis and Metronidazole Treatment Failure for Trichomonas vaginalis. Frechtling D; Chopra S; Ratnayake A; Kissinger PJ Sex Transm Dis; 2024 Jan; 51(1):61-64. PubMed ID: 37921835 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365 [TBL] [Abstract][Full Text] [Related]
9. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132 [TBL] [Abstract][Full Text] [Related]
10. Premature with trichomoniasis: report of one case. Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336 [TBL] [Abstract][Full Text] [Related]
11. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. Kissinger P BMC Infect Dis; 2015 Aug; 15():307. PubMed ID: 26242185 [TBL] [Abstract][Full Text] [Related]
12. Resistance of Trichomonas vaginalis infections to metronidazole in Auckland sexual health clinics: report of two cases. Lo M; Reid M; Brokenshire M N Z Med J; 2002 Aug; 115(1160):U147. PubMed ID: 12362204 [No Abstract] [Full Text] [Related]